ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB)

96 filings reported holding ENZB - ENZO BIOCHEM INC - Common Stock, par value $0.01 per share as of Q4 2018.
ENZO BIOCHEM INC - Common Stock, par value $0.01 per share (ENZB) has 80 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 31.8M shares of 52.3M outstanding shares and own 60.8% of the company stock.
Largest 10 shareholders include Evermore Global Advisors, LLC (4.53M shares), WELLINGTON MANAGEMENT GROUP LLP (4.16M shares), BlackRock Inc. (4.01M shares), RENAISSANCE TECHNOLOGIES LLC (3.09M shares), MANUFACTURERS LIFE INSURANCE COMPANY, THE (2.94M shares), DIMENSIONAL FUND ADVISORS LP (2.03M shares), HARBERT FUND ADVISORS, INC. (1.61M shares), Vanguard Group Inc (1.35M shares), Roumell Asset Management, LLC (1.11M shares), and STATE STREET CORP (730K shares).
This table shows the top 80 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.